AAPL325.54-8.21 (-2.46%) ▼|ABBV253.40-1.09 (-0.43%) ▼|ABT102.02+1.34 (+1.33%) ▲|ACN145.40+1.83 (+1.27%) ▲|ADBE235.68-1.57 (-0.66%) ▼|AMAT531.11+1.45 (+0.27%) ▲|AMD515.74+19.98 (+4.03%) ▲|AMGN365.03-1.26 (-0.34%) ▼|AMT166.93-3.14 (-1.84%) ▼|AMZN250.62+3.39 (+1.37%) ▲|AVGO381.45+10.63 (+2.87%) ▲|AXP353.90-1.45 (-0.41%) ▼|BA211.00-3.03 (-1.42%) ▼|BAC60.73-0.55 (-0.89%) ▼|BKNG178.73-2.95 (-1.62%) ▼|BLK1,060.59-11.61 (-1.08%) ▼|BMY60.49-0.26 (-0.42%) ▼|BNY157.70+0.57 (+0.36%) ▲|BRK-B491.60+0.69 (+0.14%) ▲|C129.59+0.23 (+0.17%) ▲|CAT868.18-10.47 (-1.19%) ▼|CL91.36-1.09 (-1.18%) ▼|CMCSA23.89+0.10 (+0.42%) ▲|COF208.42+0.39 (+0.19%) ▲|COP116.15+1.44 (+1.26%) ▲|COST933.76-7.12 (-0.76%) ▼|CRM175.10+4.33 (+2.54%) ▲|CSCO111.71-0.23 (-0.21%) ▼|CVS107.65+0.18 (+0.16%) ▲|CVX189.96+2.58 (+1.38%) ▲|DE587.55-9.69 (-1.62%) ▼|DHR203.07-0.76 (-0.37%) ▼|DIS96.40-1.27 (-1.30%) ▼|DUK125.50+0.49 (+0.39%) ▲|EMR136.77-2.77 (-1.99%) ▼|FDX307.11-5.88 (-1.88%) ▼|GD372.06+3.48 (+0.94%) ▲|GE342.36-6.47 (-1.85%) ▼|GEV1,083.97+26.13 (+2.47%) ▲|GILD133.28-1.00 (-0.74%) ▼|GM75.75-0.32 (-0.42%) ▼|GOOG352.58+6.46 (+1.87%) ▲|GOOGL352.75+5.98 (+1.72%) ▲|GS1,060.22-5.00 (-0.47%) ▼|HD333.03-5.84 (-1.72%) ▼|HON226.74+1.72 (+0.76%) ▲|IBM215.73+3.06 (+1.44%) ▲|INTC98.62+3.58 (+3.77%) ▲|INTU294.96+3.87 (+1.33%) ▲|ISRG352.49+7.07 (+2.05%) ▲|JNJ249.24-3.80 (-1.50%) ▼|JPM339.37-1.73 (-0.51%) ▼|KO81.52-0.05 (-0.06%) ▼|LIN512.20-1.02 (-0.20%) ▼|LLY1,157.15-21.97 (-1.86%) ▼|LMT511.92+3.15 (+0.62%) ▲|LOW204.73-4.00 (-1.92%) ▼|LRCX309.18-4.12 (-1.32%) ▼|MA546.28+2.68 (+0.49%) ▲|MCD267.09-0.62 (-0.23%) ▼|MDLZ60.28-0.72 (-1.18%) ▼|MDT83.87+0.67 (+0.81%) ▲|META649.28+3.27 (+0.51%) ▲|MMM161.04+1.20 (+0.75%) ▲|MO74.31+0.10 (+0.13%) ▲|MRK124.99-2.52 (-1.97%) ▼|MS211.19-4.31 (-2.00%) ▼|MSFT401.90+8.08 (+2.05%) ▲|MU880.60+31.65 (+3.73%) ▲|NEE87.89-0.91 (-1.02%) ▼|NFLX67.35-1.60 (-2.32%) ▼|NKE43.35-0.41 (-0.94%) ▼|NOW105.07+1.83 (+1.77%) ▲|NVDA204.79+1.98 (+0.97%) ▲|ORCL123.55-2.86 (-2.26%) ▼|PEP134.60-2.52 (-1.84%) ▼|PFE24.85-0.21 (-0.82%) ▼|PG148.86-1.12 (-0.75%) ▼|PLTR136.21+3.83 (+2.89%) ▲|PM192.54-0.44 (-0.23%) ▼|QCOM172.62+0.84 (+0.49%) ▲|RTX195.64+2.13 (+1.10%) ▲|SBUX104.77-0.72 (-0.68%) ▼|SCHW102.49+0.93 (+0.92%) ▲|SO94.71-0.59 (-0.62%) ▼|SPG228.78+0.08 (+0.04%) ▲|T21.97+0.16 (+0.71%) ▲|TMO530.28-2.21 (-0.41%) ▼|TMUS194.47+2.04 (+1.06%) ▲|TSLA373.65-7.19 (-1.89%) ▼|TXN287.53+3.51 (+1.24%) ▲|UBER72.30-0.16 (-0.22%) ▼|UNH424.64-1.45 (-0.34%) ▼|UNP297.20-4.56 (-1.51%) ▼|UPS113.66-4.06 (-3.45%) ▼|USB63.22+0.08 (+0.13%) ▲|V361.74+3.18 (+0.89%) ▲|VZ43.50-0.10 (-0.22%) ▼|WFC86.52-0.99 (-1.13%) ▼|WMT112.29-1.95 (-1.71%) ▼|XOM148.82+1.46 (+0.99%) ▲|AAPL325.54-8.21 (-2.46%) ▼|ABBV253.40-1.09 (-0.43%) ▼|ABT102.02+1.34 (+1.33%) ▲|ACN145.40+1.83 (+1.27%) ▲|ADBE235.68-1.57 (-0.66%) ▼|AMAT531.11+1.45 (+0.27%) ▲|AMD515.74+19.98 (+4.03%) ▲|AMGN365.03-1.26 (-0.34%) ▼|AMT166.93-3.14 (-1.84%) ▼|AMZN250.62+3.39 (+1.37%) ▲|AVGO381.45+10.63 (+2.87%) ▲|AXP353.90-1.45 (-0.41%) ▼|BA211.00-3.03 (-1.42%) ▼|BAC60.73-0.55 (-0.89%) ▼|BKNG178.73-2.95 (-1.62%) ▼|BLK1,060.59-11.61 (-1.08%) ▼|BMY60.49-0.26 (-0.42%) ▼|BNY157.70+0.57 (+0.36%) ▲|BRK-B491.60+0.69 (+0.14%) ▲|C129.59+0.23 (+0.17%) ▲|CAT868.18-10.47 (-1.19%) ▼|CL91.36-1.09 (-1.18%) ▼|CMCSA23.89+0.10 (+0.42%) ▲|COF208.42+0.39 (+0.19%) ▲|COP116.15+1.44 (+1.26%) ▲|COST933.76-7.12 (-0.76%) ▼|CRM175.10+4.33 (+2.54%) ▲|CSCO111.71-0.23 (-0.21%) ▼|CVS107.65+0.18 (+0.16%) ▲|CVX189.96+2.58 (+1.38%) ▲|DE587.55-9.69 (-1.62%) ▼|DHR203.07-0.76 (-0.37%) ▼|DIS96.40-1.27 (-1.30%) ▼|DUK125.50+0.49 (+0.39%) ▲|EMR136.77-2.77 (-1.99%) ▼|FDX307.11-5.88 (-1.88%) ▼|GD372.06+3.48 (+0.94%) ▲|GE342.36-6.47 (-1.85%) ▼|GEV1,083.97+26.13 (+2.47%) ▲|GILD133.28-1.00 (-0.74%) ▼|GM75.75-0.32 (-0.42%) ▼|GOOG352.58+6.46 (+1.87%) ▲|GOOGL352.75+5.98 (+1.72%) ▲|GS1,060.22-5.00 (-0.47%) ▼|HD333.03-5.84 (-1.72%) ▼|HON226.74+1.72 (+0.76%) ▲|IBM215.73+3.06 (+1.44%) ▲|INTC98.62+3.58 (+3.77%) ▲|INTU294.96+3.87 (+1.33%) ▲|ISRG352.49+7.07 (+2.05%) ▲|JNJ249.24-3.80 (-1.50%) ▼|JPM339.37-1.73 (-0.51%) ▼|KO81.52-0.05 (-0.06%) ▼|LIN512.20-1.02 (-0.20%) ▼|LLY1,157.15-21.97 (-1.86%) ▼|LMT511.92+3.15 (+0.62%) ▲|LOW204.73-4.00 (-1.92%) ▼|LRCX309.18-4.12 (-1.32%) ▼|MA546.28+2.68 (+0.49%) ▲|MCD267.09-0.62 (-0.23%) ▼|MDLZ60.28-0.72 (-1.18%) ▼|MDT83.87+0.67 (+0.81%) ▲|META649.28+3.27 (+0.51%) ▲|MMM161.04+1.20 (+0.75%) ▲|MO74.31+0.10 (+0.13%) ▲|MRK124.99-2.52 (-1.97%) ▼|MS211.19-4.31 (-2.00%) ▼|MSFT401.90+8.08 (+2.05%) ▲|MU880.60+31.65 (+3.73%) ▲|NEE87.89-0.91 (-1.02%) ▼|NFLX67.35-1.60 (-2.32%) ▼|NKE43.35-0.41 (-0.94%) ▼|NOW105.07+1.83 (+1.77%) ▲|NVDA204.79+1.98 (+0.97%) ▲|ORCL123.55-2.86 (-2.26%) ▼|PEP134.60-2.52 (-1.84%) ▼|PFE24.85-0.21 (-0.82%) ▼|PG148.86-1.12 (-0.75%) ▼|PLTR136.21+3.83 (+2.89%) ▲|PM192.54-0.44 (-0.23%) ▼|QCOM172.62+0.84 (+0.49%) ▲|RTX195.64+2.13 (+1.10%) ▲|SBUX104.77-0.72 (-0.68%) ▼|SCHW102.49+0.93 (+0.92%) ▲|SO94.71-0.59 (-0.62%) ▼|SPG228.78+0.08 (+0.04%) ▲|T21.97+0.16 (+0.71%) ▲|TMO530.28-2.21 (-0.41%) ▼|TMUS194.47+2.04 (+1.06%) ▲|TSLA373.65-7.19 (-1.89%) ▼|TXN287.53+3.51 (+1.24%) ▲|UBER72.30-0.16 (-0.22%) ▼|UNH424.64-1.45 (-0.34%) ▼|UNP297.20-4.56 (-1.51%) ▼|UPS113.66-4.06 (-3.45%) ▼|USB63.22+0.08 (+0.13%) ▲|V361.74+3.18 (+0.89%) ▲|VZ43.50-0.10 (-0.22%) ▼|WFC86.52-0.99 (-1.13%) ▼|WMT112.29-1.95 (-1.71%) ▼|XOM148.82+1.46 (+0.99%) ▲|
27.1 C
New York
Monday, July 20, 2026

Tag: net sales

Ingredion Names Kenneth Escoe to Board of Directors

Ingredion names Kenneth Escoe to its Board, adding global operations, M&A and industrial leadership expertise to support long-term growth.

DKSH Enters Strategic Distribution Partnership with BridgeBio to Support Regulatory Evaluation and Potential Patient Access to Transthyretin Stabilizer for ATTR-CM in Selected Asia Pacific...

SINGAPORE, June 11, 2026 /PRNewswire/ -- DKSH entered a strategic distribution partnership with BridgeBio to support regulatory evaluation and potential patient access to a...

Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy 

TEL AVIV, Israel, June 10, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the closing of Teva’s acquisition of Emalex Biosciences, strengthening its late-stage pipeline with ecopipam and further advancing its Pivot to Growth strategy. Phase 3 data for ecopipam were recently published in JAMA Neurology, and a U.S. NDA submission is anticipated in the second half of 2026. 

Suominen Oyj – Managers’ Transactions: Charles Héaulmé

Charles Héaulmé has reported to have made transactions with Suominen Corporation's shares. The transactions are presented below as a summary, and in detail as per the disclosure requirement.

Suja Life Reports First Quarter 2026 Financial Results

Net sales increased 22.5% year-over-year to $107.1 million

Valmet’s solution boosts Gren Tartu’s district heating capacity in Estonia with flue gas heat recovery

Valmet Oyj's press release June 9, 2026, at 10:00 a.m. EESTESPOO, Finland, June 9, 2026 /PRNewswire/ -- Valmet has received an order from Gren...

Mama’s Creations Reports First Quarter Fiscal 2027 Financial Results

First Quarter Revenue Grows 50% to $52.8 Million; Net Income Increases 66% to $2.1 Million with Adjusted EBITDA Up 71% to $4.9 Million; Cash Position Grows to $24.4 Million

Mission Produce® Announces Fiscal 2026 Second Quarter Financial Results

Acquisition of Calavo Growers completed May 28, 2026

New Transcribe carpet tile, LVT collection from Tarkett inspires human connectivity, expression

SOLON, Ohio, June 8, 2026 /PRNewswire/ -- From ancient etchings to contemporary icons, human beings have always had an enduring instinct to communicate through...

Suominen Corporation – Manager’s transaction: Charles Héaulmé

Suominen Corporation June 8, 2026 at 1:30 p.m. (EEST)

Decisions taken by Suominen Corporation’s Extraordinary General Meeting

Suominen Corporation’s stock exchange release on June 8, 2026, at 10:30 a.m. (EEST)

LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China

The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027
The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027

HELE Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Helen of Troy Limited. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Helen of Troy Limited (HELE) Misled Investors Regarding the Ability of Project Pegasus to Improve Efficiency

G-III Apparel Group, LTD. Reports First Quarter Fiscal 2027 Results and Raises Earnings Guidance

NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- G-III Apparel Group, Ltd. (NasdaqGS: GIII) (“G-III” or the “Company”) today reported results for the first quarter of fiscal year 2027, ended April 30, 2026.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsNet sales